Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
19
datasets available to search
ShareScore release 0.9.0
Dataset results
19 results for “worker safety”
Data from: Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial
<p>Morbidity and mortality attributable to COVID-19 is devastating global health systems and economies. Bacillus Calmette Guérin (BCG) vaccination has been in use for many decades to prevent severe forms of tuberculosis in children. Studies have also shown a combination of improved long-term innate or trained immunity (through epigenetic reprogramming of myeloid cells) and adaptive responses after BCG vaccination, which leads to non-specific protective effects in adults. Observational studies have shown that countries with routine BCG vaccination programs have significantly less reported cases and deaths of COVID-19, but such studies are prone to significant bias and need confirmation. To date, in the absence of direct evidence, WHO does not recommend BCG for the prevention of COVID-19. This project aims to investigate in a timely manner whether and why BCG-revaccination can reduce infection rate and/or disease severity in health care workers during the SARS-CoV-2 outbreak in South Africa. </p> <p>These objectives will be achieved with a blinded, randomised controlled trial of BCG revaccination versus placebo in exposed front-line staff in hospitals in Cape Town. Observations will include the rate of infection with COVID-19 as well as the occurrence of mild, moderate or severe ambulatory respiratory tract infections, hospitalisation, need for oxygen, mechanical ventilation or death. HIV-positive individuals will be excluded. Safety of the vaccines will be monitored. A secondary endpoint is the occurrence of latent or active tuberculosis. Initial sample size and follow-up duration is at least 500 workers and 52 weeks. Statistical analysis will be model-based and ongoing in real time with frequent interim analyses and optional increases of both sample size or observation time, based on the unforeseeable trajectory of the South African COVID-19 epidemic, available funds and recommendations of an independent data and safety monitoring board. The study will be supported by a novel 3D lung organoid model of SARS-CoV-2 infection system that can mimic the cascade of immunological events after SARS-CoV-2 infection to determine and analyse the contribution of cellular components to the impact of BCG revaccination in this study.</p> <p>Given the immediate threat of the SARS-CoV-2 epidemic the trial has been designed as a pragmatic study with highly feasible endpoints that can be continuously measured. This allows for the most rapid identification of a beneficial outcome that would lead to immediate dissemination of the results, vaccination of the control group and outreach to the health authorities to consider BCG vaccination for all qualifying health care workers.</p>
Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age
ClinicalTrials.gov study NCT01768117. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial
Open the record for dataset details and reuse information.
Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy
ClinicalTrials.gov study NCT04014426. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety and Immunogenicity of an Inactivated Vaccine Against COVID-19 in Medical Workers
ClinicalTrials.gov study NCT04795414. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Interactive Virtual Occupational Safety Training Designed for Home Healthcare Workers
ClinicalTrials.gov study NCT06974708. IPD Sharing: NO. Countries: 1. Publications: 5.
Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic
ClinicalTrials.gov study NCT04576299. IPD Sharing: UNDECIDED. Countries: 4. Publications: 3.
A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix
ClinicalTrials.gov study NCT00503165. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Evaluation of COMmunity of Practice And Safety Support (COMPASS) for Home Care Workers
ClinicalTrials.gov study NCT02113371. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Project A: Integrated Approaches to Improving the Health and Safety of Health Care Workers
ClinicalTrials.gov study NCT01841983. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Effectiveness of the Adsorbed Vaccine COVID-19 (Coronavac) Among Education and Public Safety Workers With Risk Factors for Severity
ClinicalTrials.gov study NCT04789356. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Incre
ClinicalTrials.gov study NCT04359680. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Hepatitis B vaccination coverage, knowledge and sociodemographic determinants of uptake in high risk public safety workers in Kaduna State, Nigeria: a cross sectional survey
Open the record for dataset details and reuse information.
Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers
ClinicalTrials.gov study NCT04461379. IPD Sharing: NO. Countries: 1. Publications: 0.
Demonstrating Safety and Effective Delivery of Daily Oral Pre-exposure Prophylaxis (PrEP) for Sex Workers in India
ClinicalTrials.gov study NCT02148094. IPD Sharing: NO. Countries: 1. Publications: 0.
Protecting Home Healthcare Workers: An Interactive Video-based App to Coach Workers Through Challenging Health and Safety-related Situations
ClinicalTrials.gov study NCT04593901. IPD Sharing: NO. Countries: 1. Publications: 0.
The Safety Integration Stakeholders (SAINTS) Program to Integrate Worker and Patient Safety in Oregon Rural Hospitals
ClinicalTrials.gov study NCT06302088. IPD Sharing: NO. Countries: 0. Publications: 0.
Point cloud data for worker safety project
<p>This three files are the scanned data for the worker safety project. The scanned location includes two urban intersections and a part of an urban highway. These three files can be opened by Autodesk Recap, which is a point cloud manipulating software. This data can be requested by contacting Dr. Semiha Ergan at semiha@nyu.edu</p>
Biometric sensor and smartwatch response data collected during VR user studies for Worker Safety III
<p>Two related datasets are included documenting users' sensor data and responses to alarms on a smartwatch during virtrual reality (VR) worker safety experiments on an integrated traffic simulation and VR platform.</p> <ul> <li><strong>watchData.csv </strong>records the times at which the user received an alarm on an Apple Watch and times when they tapped the watch screen to acknowledge the alarm.</li> <li><strong>HRData.csv</strong> records blood volume pulse (BVP), inter-beat interval (IBI), and heart rate (HR) data for each user Data was recorded using an Empatica E4 PPG (photoplethysmography) wristband.</li> </ul> <p>Both csv files shared the same column headers with the following descriptions:</p> <ul> <li>UserID - Each user has a unique 4 digit ID randomly assigned to them at their first VR experiment.</li> <li>Scenario - Indicates which work zone safety Scenario the user experienced. <ul> <li>Scenario 1: Placing cones in a mobile work zone</li> <li>Scenario 2: Sensor installation on highway</li> <li>Scenario 3: Surveying in urban intersections</li> </ul> </li> <li>Trial - Indicates how many times they have experienced the same VR scenario (i.e. Scenario 3, Trial 2 means the user is experiencing Scenario 3 for the second time)</li> <li>VibrationOnly - Indicates the modality of alarms the user received during the trial. <ul> <li>VibrationOnly = 1 indicates that the alarms were haptic/vibrations only.</li> <li>VibrationOnly = 0 indicates that the alarms were haptic/vibrations AND sounds.</li> </ul> </li> <li>Timestamp - Local timestamp of the data recording</li> <li>Time Elapsed - Time that has passed since the start of the trial</li> <li>From - Indicates the source of the data <ul> <li>From = PPG - indicates the data is from the heart rate sensor</li> <li>From = Watch - indicates the data is from the Apple smartwatch, generally applies to when the user has responded on the watch/acknowledged the watch alarm</li> <li>From = VR - indicates the data is from the traffic simulation, generally applies to when speeding/collision cars trigger an alarm on the Apple smartwatch</li> <li>From = Ultrasonic - indicates the data is from an ultrasonic sensor detecting when the user was on the edge of the work zone perimeter.</li> </ul> </li> <li>Event - indicates the event being recorded <ul> <li>BVP/IBI/HR - indicates the meaning of the three numbers in the Values column (see Values below)</li> <li>Start Simulation - indicates when the trial began</li> <li>Received car approaching alert, <strong>mode=x, id=xxx</strong> <ul> <li><strong>Mode </strong>indicates the type of alarm duration, frequency, and number of repetitions.</li> <li>ID indicates the cause of the alarm</li> </ul> </li> </ul> </li> <li>Type - indicates additional categorizations of events <ul> <li>Speeding/Collision - indicates the alarm was caused by a speeding or collision car</li> <li>Perimeter - indicates the alarm was triggered when the user was on the edge of the work zone perimeter.</li> <li>Response - indicates the user responded/acknowledged the alarm on the smartwatch by tapping the watch screen.</li> <li>BVP/IBI/HR - indicates the meaning of the three numbers in the Values column (see Values below)</li> </ul> </li> <li>Values <ul> <li>For Type=Response, Values indicates the alarm id the user responded to. Response time has to be calculated by subtracting the Time Elapsed of the Response row with the corresponding Time Elapsed of the alarm id row</li> <li>For Type="Received...", Values indicates the alarm mode and id</li> <li>For Type=BVP/IBI/HR, three values are listed indicating respectively blood volume pulse (BVP), inter-beat interval (IBI), and heart rate (HR) data</li> </ul> </li> </ul> <p>Data requests and inquiries can be made by contacting Dr. Semiha Ergan at semiha@nyu.edu</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.